Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2024 16:05 ET | Source: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone reports second quarter 2024 financial results and provides recent business highlights
May 13, 2024 17:01 ET | Source: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
February 21, 2024 06:00 ET | Source: Turnstone Biologics Corp.

Turnstone Biologics to Participate in Upcoming Investor Conferences

Turnstone to present and participate in TD Cowen 44th Annual Global Health Care Conference and Leerink Partners Global Biopharma Conference 2024.
November 27, 2023 06:00 ET | Source: Turnstone Biologics Corp.

Turnstone Biologics to Participate in the Piper Sandler 35th Annual Healthcare Conference

Dr. Sammy Farah, President and CEO of Turnstone, will participate in a fireside chat at the Piper Sandler 35th Annual Healthcare Conference in New York.
November 09, 2023 21:49 ET | Source: Turnstone Biologics Corp.

Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Corp. Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
November 03, 2023 06:00 ET | Source: Turnstone Biologics Corp.

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Posters showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for solid tumors.